Overview

Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation

Status:
Terminated

Trial end date:
2014-05-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate whether dabigatran reduces clopidogrel mediated ADP induced platelet aggregation measured by MEA as compared to phenprocoumon after a two-week treatment with either agent.

Phase:

Phase 4

Details

Lead Sponsor:

Deutsches Herzzentrum Muenchen

Treatments:

Clopidogrel
Dabigatran
Phenprocoumon